Is Inghams Group Ltd a buy at this share price?

Shares in Inghams Group Ltd (ASX:ING) have been quite steady since their debut in November.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With its first 'half-year' since listing now completed, Inghams Group Ltd (ASX: ING) shareholders will soon get the opportunity to see the company's progress in a few short weeks, when the half-year results come out in February.

Given that the value of shares hasn't really budged since listing, and that the upcoming interim results will reflect mostly the company's ownership under TPG, I still think investors are better off avoiding the company.

NZ competitor TEGEL GRP FPO NZX (ASX: TGH) – Tegel – also raised some concerns last month when it released its quarterly report, showing an increase in market share at the cost of lower prices per kilogram. This type of market share grab could prove destructive for both companies, with Inghams potentially losing market share in NZ, and Tegel possibly taking a meaningful hit to its profit margins as a result of the lower prices. Inghams' profits could come under fire if it is forced to cut prices to compete.

As the incumbent, Inghams likely has a scale advantage over competitor Tegel, and possibly a product advantage as well in terms of processing ('value-adding') facilities. Tegel, however, doesn't have a lot to lose by having a crack at expanding into Australia, and recent developments have reportedly made it easier for the company to export products here. Investors also shouldn't forget the potential for pressure from the big supermarkets, who are ultimately Inghams' and Tegel's biggest customers.

There are several key things I will be looking for in Inghams' upcoming results, and all of them concern the group's competitive position and margins. Based on what I've seen recently however, I still think investors should avoid Inghams entirely.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »